Awakn Life Sciences (Awakn Life Sciences) LT-Debt-to-Total-Asset : 0.00 (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Awakn Life Sciences's long-term debt to total assests ratio for the quarter that ended in Oct. 2023 was 0.00.

Awakn Life Sciences's long-term debt to total assets ratio declined from Oct. 2022 (0.31) to Oct. 2023 (0.00). It may suggest that Awakn Life Sciences is progressively becoming less dependent on debt to grow their business.

Awakn Life Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Awakn Life Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences LT-Debt-to-Total-Asset Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

LT-Debt-to-Total-Asset

0.14

0.21

0.43

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial							0.31	0.43	0.46	-	-

Awakn Life Sciences LT-Debt-to-Total-Asset Calculation

Awakn Life Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jan. 2023 is calculated as

LT Debt to Total Assets (A: Jan. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Jan. 2023 )	/	Total Assets (A: Jan. 2023 )
	=	1.422	/	3.274
	=	0.43

Awakn Life Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Oct. 2023 is calculated as

LT Debt to Total Assets (Q: Oct. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Oct. 2023 )	/	Total Assets (Q: Oct. 2023 )
	=	0	/	0.796
	=	0.00

Awakn Life Sciences (OTCPK:AWKNF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Awakn Life Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences (Awakn Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

954:Germany AWKN:Canada

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines

From GuruFocus

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 06-21-2022

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

By PRNewswire PRNewswire • 10-11-2021

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By PurpleRose PurpleRose • 07-11-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 07-01-2022